This may be of interest to those of you on Levothyroxine
nature.com/nrendo/journal/v...
Precision in the dosing of levothyroxine (LT4) products is guided by sensitive TSH measurements, and is essential to optimize therapeutic outcomes and assure patient safety. FDA regulation of LT4 formulations aims to provide consistent drug content and bioavailability of the individual products approved for distribution in the US.1, 2 What is unclear at this point, however, is whether true generic interchangeability among approved products has been achieved.